58 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
or directors of the Company pursuant to any stock or option plan duly adopted for such purpose by a majority of the non-employee members of the Board … of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
stock to decline. A substantial majority of the outstanding shares of our common stock are, and the shares of common stock offered hereby will be, freely … vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors
424B5
wmtct v4ja
11 Mar 24
Prospectus supplement for primary offering
4:06pm
424B4
gqvqwnl76qmxkh6m9op
8 Jan 24
Prospectus supplement with pricing info
4:11pm
S-3
EX-4.4
mvc1cs7e
23 Dec 22
Shelf registration
4:16pm
S-3
wrgvc43gehwf
23 Dec 22
Shelf registration
4:16pm
8-K
EX-99.1
2j9e0n
16 Nov 22
Developing disease - modifying medicines for degenerative disorders November 2022
5:18pm
424B4
tm8f vyz22r
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
pk01usm
20 Oct 22
Draft registration statement
12:00am
DEF 14A
pfrn we84y88wyychqh
25 Apr 22
Definitive proxy
5:28pm
10-K
EX-4.1
i20n o3b0
30 Mar 22
Annual report
7:40am
10-K
bxlmk bc7dp4fb1sx
30 Mar 22
Annual report
7:40am
10-Q
9o6 w93l2
17 Nov 21
Quarterly report
5:15pm